Currently predicting for Thu, 4 Jun 2026

ANNX Prediction Chart

ANNX Predictions History

Latest community submissions for ANNX.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 10, 2026 $5.80 +3.00% $5.61 X 96.63% 0
Feb 10, 2026 $5.74 +1.87% $5.61 X 97.76% 0
Feb 10, 2026 $5.55 -3.14% $5.61 V 98.93% 2
Jan 26, 2026 $6.61 -2.45% $6.66 V 99.31% 4
Jan 26, 2026 $6.68 -1.53% $6.66 V 99.76% 6
Jan 26, 2026 Bullish $6.66 X 0
Jan 23, 2026 $6.79 -2.38% $6.78 V 99.79% 6
Jan 23, 2026 $6.86 -1.49% $6.78 V 98.87% 2
Jan 23, 2026 Bullish $6.78 X 0
Jan 21, 2026 $6.32 +2.65% $6.85 V 92.31% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ANNX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ANNEXON INC.
Annexon
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/II...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE